Moneycontrol
HomeNewsBusinessMarketsBuy Abbott India, target Rs 8,450: Dharmesh Shah

Buy Abbott India, target Rs 8,450: Dharmesh Shah

We expect the stock to resume fresh up move and test levels of Rs 8450 levels in the medium term, says Dharmesh Shah of ICICI Securities.

December 27, 2018 / 12:11 IST
Story continues below Advertisement
Abbott India | The company's year-on-year sales and profit growth numbers for FY20 were 11.27% and 31.67%, respectively. In the past one year, the stock price rose 93 percent to Rs 16,965.00 as on August 24, 2020. Objective: To increase presence in the Indian branded generics space. Result: Expensive deal with Abbott paying 8.8 times of Piramal sales. While the acquisition strengthened Abbott’s market position and product portfolio in India, sales growth are highly unlikely to reach Abbott’s USD 2.5 billion revenue target for 2020. (Image Reuters)

Dharmesh Shah

Abbott India is in secular uptrend as it continues to form higher peak and higher trough in the monthly chart and is seen trading in a rising channel highlighting sustained buying demand at elevated levels. The last three month corrections has seen the stock testing the lower band of the channel thus providing fresh entry opportunity to ride the next up move in the stock.

Story continues below Advertisement

The share price of Abbott India has registered a breakout above multiyear highs around Rs 6170 levels during middle of previous year. The stock post the breakout has rallied and hit an all time high of Rs 8820 during September 2018. The last three months sideways corrective consolidation has helped the stock work off the overbought condition developed after the previous sharp rally. The stock is currently placed at the major support area of Rs 6900-7100 being the confluence of:

- The lower band of the rising channel placed since CY’17